TripSit.ai Information

The platform brings together published research, clinical trials, drug labels, disease society resources, congress material and other relevant sources. It organizes that evidence through clinically grounded ontologies, knowledge graphs and taxonomies, connecting therapies, diseases, indications and patient populations without losing the distinctions that matter. TripSit combines scientific evidence with patient experience to develop disease landscapes, therapy profiles, competitive analyses, patient journeys and unmet-needs insights. It supports teams across medical affairs, clinical development, commercial strategy and market access. Our principle is straightforward: evidence first, interpretation second. Deep medical search and independent source checks establish the foundation. AI helps interpret the findings and develop useful insights, not invent the evidence behind them. The result is a reusable intelligence platform that helps teams understand what is known, where the gaps are and what the evidence means for their decisions.